ORACLE INVESTMENT MANAGEMENT INC - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 130 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.21 and the average weighting 0.3%.

Quarter-by-quarter ownership
ORACLE INVESTMENT MANAGEMENT INC ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2014$24,848,474,000
+9.3%
1,620,905
-12.2%
3.02%
+16.1%
Q1 2014$22,742,782,000
+81.2%
1,846,005
+70.8%
2.60%
+50.3%
Q4 2013$12,550,468,000
-4.2%
1,081,005
-2.3%
1.73%
-7.5%
Q3 2013$13,095,099,000
+19.1%
1,106,005
-0.1%
1.87%
-1.5%
Q2 2013$10,993,324,0001,107,0821.90%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q2 2013
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$172,422,80022.05%
13D Management LLC 533,562$5,613,0732.85%
Quantedge Capital Pte Ltd 541,200$5,693,4242.22%
Price Jennifer C. 520,000$5,470,4001.74%
Tamarack Advisers, LP 210,000$2,209,2000.81%
Intrinsic Value Partners, LLC 51,605$542,8850.73%
Brown Capital Management 3,933,933$41,384,9750.62%
Old West Investment Management, LLC 75,219$791,3030.43%
EMC Capital Management 43,315$4560.38%
Hillsdale Investment Management Inc. 420,617$4,424,8910.38%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders